Quadrant Capital Group LLC Charles River Laboratories International, Inc. Transaction History

Quadrant Capital Group LLC

  • $1.42 Billion
  • Q3 2024

A detailed history of Quadrant Capital Group LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 465 shares of CRL stock, worth $84,699. This represents 0.01% of its overall portfolio holdings.

Number of Shares
465
Previous 470 1.06%
Holding current value
$84,699
Previous $97,000 6.19%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$187.96 - $245.29 $939 - $1,226
-5 Reduced 1.06%
465 $91,000
Q1 2024

May 15, 2024
SELL
$203.52 - $273.43 $3,459 - $4,648
-17 Reduced 3.49%
470 $127,000
Q4 2023

Feb 08, 2024
BUY
$164.52 - $238.84 $18,097 - $26,272
110 Added 29.18%
487 $115,000
Q3 2023

Nov 14, 2023
SELL
$194.44 - $217.61 $1,166 - $1,305
-6 Reduced 1.57%
377 $73,000
Q2 2023

Aug 09, 2023
SELL
$183.71 - $210.25 $8,634 - $9,881
-47 Reduced 10.93%
383 $80,000
Q1 2023

May 11, 2023
SELL
$191.89 - $259.92 $10,937 - $14,815
-57 Reduced 11.7%
430 $86,000
Q3 2022

Nov 10, 2022
SELL
$182.44 - $250.54 $4,561 - $6,263
-25 Reduced 4.88%
487 $96,000
Q2 2022

Aug 09, 2022
BUY
$204.13 - $302.4 $18,575 - $27,518
91 Added 21.62%
512 $110,000
Q1 2022

May 06, 2022
SELL
$255.51 - $362.11 $15,586 - $22,088
-61 Reduced 12.66%
421 $120,000
Q4 2021

Feb 01, 2022
SELL
$351.38 - $448.68 $7,027 - $8,973
-20 Reduced 3.98%
482 $182,000
Q3 2021

Nov 12, 2021
BUY
$372.64 - $458.3 $9,688 - $11,915
26 Added 5.46%
502 $207,000
Q2 2021

Aug 09, 2021
BUY
$294.17 - $371.65 $4,412 - $5,574
15 Added 3.25%
476 $176,000
Q1 2021

May 12, 2021
BUY
$249.67 - $299.48 $18,225 - $21,862
73 Added 18.81%
461 $134,000
Q4 2020

Feb 16, 2021
SELL
$222.0 - $252.62 $3,996 - $4,547
-18 Reduced 4.43%
388 $97,000
Q2 2020

Aug 13, 2020
SELL
$118.84 - $189.72 $24,362 - $38,892
-205 Reduced 33.55%
406 $71,000
Q1 2020

May 15, 2020
BUY
$98.9 - $178.34 $21,758 - $39,234
220 Added 56.27%
611 $77,000
Q2 2019

Jul 24, 2019
SELL
$123.4 - $148.55 $40,105 - $48,278
-325 Reduced 45.39%
391 $52,000
Q1 2019

Apr 29, 2019
BUY
$104.82 - $146.73 $34,066 - $47,687
325 Added 83.12%
716 $100,000
Q3 2018

Oct 29, 2018
BUY
$112.11 - $134.54 $12,219 - $14,664
109 Added 38.65%
391 $50,000
Q3 2017

Oct 13, 2017
BUY
$96.72 - $109.26 $7,834 - $8,850
81 Added 40.3%
282 $27,000
Q2 2017

Aug 15, 2017
BUY
N/A
201
201 $14,000

Others Institutions Holding CRL

# of Institutions
695
Shares Held
52.2M
Call Options Held
259K
Put Options Held
463K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.26B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email